EU ministers urge incentives for R&D into new antibiotics
This article was originally published in SRA
Executive Summary
R&D into new antibiotics has declined significantly and will probably not yield enough new products to meet medical needs within the next five to ten years. There is, therefore, an “urgent need” to create incentives for research into new therapeutics, according to European Union health ministers.